Literature DB >> 28743432

High levels of eukaryotic Initiation Factor 6 (eIF6) are required for immune system homeostasis and for steering the glycolytic flux of TCR-stimulated CD4+ T cells in both mice and humans.

Nicola Manfrini1, Sara Ricciardi2, Annarita Miluzio2, Maya Fedeli3, Alessandra Scagliola4, Simone Gallo4, Daniela Brina5, Thure Adler6, Dirk H Busch7, Valerie Gailus-Durner6, Helmut Fuchs6, Martin Hrabě de Angelis8, Stefano Biffo9.   

Abstract

Eukaryotic Initiation Factor 6 (eIF6) is required for 60S ribosomal subunit biogenesis and efficient initiation of translation. Intriguingly, in both mice and humans, endogenous levels of eIF6 are detrimental as they act as tumor and obesity facilitators, raising the question on the evolutionary pressure that maintains high eIF6 levels. Here we show that, in mice and humans, high levels of eIF6 are required for proper immune functions. First, eIF6 heterozygous (het) mice show an increased mortality during viral infection and a reduction of peripheral blood CD4+ Effector Memory T cells. In human CD4+ T cells, eIF6 levels rapidly increase upon T-cell receptor activation and drive the glycolytic switch and the acquisition of effector functions. Importantly, in CD4+ T cells, eIF6 levels control interferon-γ (IFN-γ) secretion without affecting proliferation. In conclusion, the immune system has a high evolutionary pressure for the maintenance of a dynamic and powerful regulation of the translational machinery.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD4(+) T cells; Effector functions; Glycolysis; Immune system; Metabolism; eIF6

Mesh:

Substances:

Year:  2017        PMID: 28743432     DOI: 10.1016/j.dci.2017.07.022

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  5 in total

1.  Robust T cell activation requires an eIF3-driven burst in T cell receptor translation.

Authors:  Dasmanthie De Silva; Lucas Ferguson; Grant H Chin; Benjamin E Smith; Ryan A Apathy; Theodore L Roth; Franziska Blaeschke; Marek Kudla; Alexander Marson; Nicholas T Ingolia; Jamie Hd Cate
Journal:  Elife       Date:  2021-12-31       Impact factor: 8.140

2.  eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma.

Authors:  Fangyingnan Zhang; Saquib Waheed; Ubaldo Armato; Jun Wu; Chao Zhang; Zhibin Li
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

3.  The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling.

Authors:  Sara Ricciardi; Nicola Manfrini; Roberta Alfieri; Piera Calamita; Maria Cristina Crosti; Simone Gallo; Rolf Müller; Massimiliano Pagani; Sergio Abrignani; Stefano Biffo
Journal:  Cell Metab       Date:  2018-09-06       Impact factor: 27.287

4.  Data on the effects of eIF6 downmodulation on the proportions of innate and adaptive immune system cell subpopulations and on thymocyte maturation.

Authors:  Nicola Manfrini; Sara Ricciardi; Annarita Miluzio; Maya Fedeli; Alessandra Scagliola; Simone Gallo; Thure Adler; Dirk H Busch; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Stefano Biffo
Journal:  Data Brief       Date:  2017-08-30

5.  Discovery and Preliminary Characterization of Translational Modulators that Impair the Binding of eIF6 to 60S Ribosomal Subunits.

Authors:  Elisa Pesce; Annarita Miluzio; Lorenzo Turcano; Claudia Minici; Delia Cirino; Piera Calamita; Nicola Manfrini; Stefania Oliveto; Sara Ricciardi; Renata Grifantini; Massimo Degano; Alberto Bresciani; Stefano Biffo
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.